Related Experiment Video

Updated: Apr 3, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.8K

Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure

Dali Yin, Konstantin V Slavin

    Progress in Neurological Surgery
    |September 23, 2015
    PubMed

    Insights

    Resistant hypertension and heart failure pose global health challenges. New baroreflex activation therapy using carotid sinus stimulation shows promise in reducing blood pressure and improving cardiac function by modulating the autonomic nervous system.

    Area of Science:

    • Cardiology
    • Neurology
    • Biomedical Engineering

    Background:

    • Hypertension and cardiovascular disease are major global health concerns.
    • Resistant hypertension and heart failure present significant treatment challenges.
    • Current therapies have limitations, necessitating novel approaches.

    Purpose of the Study:

    • To introduce a novel device-based therapy for resistant hypertension and heart failure.
    • To describe the technology for carotid sinus stimulation.
    • To highlight the potential of baroreflex activation therapy.

    Main Methods:

    • Carotid sinus stimulation technology designed to electrically activate baroreceptors.
    • Surgical techniques for device implantation.
    • Review of clinical trial findings on carotid sinus stimulation.

    Main Results:

    • Baroreflex activation therapy may reduce sympathetic drive and increase parasympathetic activity.
    • Carotid sinus stimulation aims to lower blood pressure and enhance cardiac function.
    • Clinical trials demonstrate promising outcomes for this device-based therapy.

    Conclusions:

    • Baroreflex activation therapy offers a new treatment avenue for hypertension and heart failure.
    • Carotid sinus stimulation is a promising technology for managing cardiovascular conditions.
    • Further research and clinical application of this therapy are warranted.

    More Related Videos

    Studying the Coding Profiles of Somatic Stimulation on Cardiac-locked Neuronal Responses in the Rat Spinal Dorsal Horn07:12

    Studying the Coding Profiles of Somatic Stimulation on Cardiac-locked Neuronal Responses in the Rat Spinal Dorsal Horn

    Published on: May 23, 2025

    712
    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.9K

    Related Concept Videos

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    1.4K
    Neural Regulation of Blood Pressure01:18

    Neural Regulation of Blood Pressure

    The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
    Baroreceptor Reflex
    Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
    8.8K
    Heart Failure Drugs: β-Blockers01:22

    Heart Failure Drugs: β-Blockers

    β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
    1.1K
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    583